← 返回

复方硫酸铝注射液在移植瘤荷瘤小鼠中的抗肿瘤作用及免疫相关机制研究

英文原题:Anti-tumor effect and immune-related mechanism study of compound aluminum sulfate injection in transplanted tumor-bearing mice.

查看英文原题

Anti-tumor effect and immune-related mechanism study of compound aluminum sulfate injection in transplanted tumor-bearing mice.

PubMed 2025/05/01(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

本研究探讨了复方硫酸铝(CAS)溶液在小鼠黑色素瘤模型中的抗肿瘤和免疫调节作用。使用同基因B16-F10和B16-OVA肿瘤模型,我们证明瘤内注射CAS显著抑制原发肿瘤生长和肺转移。流式细胞术分析显示,CAS治疗增加了脾脏中CD3 + CD8 + 细胞毒性T细胞、CD3 + CD44 + 记忆T细胞和NK细胞的群体数量,同时增强了肿瘤组织中CD8 + T细胞的浸润。ELISA结果显示,CAS给药后脾脏培养上清液和血清中促炎细胞因子(IFN-γ、TNF-α和IL-2)水平升高。免疫荧光染色证实,CAS治疗小鼠肿瘤组织中CD8和IFN-γ蛋白表达增加。结果表明,CAS通过直接细胞毒性和调节全身及局部免疫反应发挥其抗肿瘤作用。CAS的双重作用将肿瘤坏死与免疫刺激相结合,使其成为癌症治疗中一种有前景的治疗剂。本研究为CAS作用的潜在机制提供了有价值的见解,并强调了其在肿瘤学中的潜在临床应用。

展开英文摘要原文

This study investigates the antitumor and immunomodulatory effects of compound aluminum sulfate (CAS) solution in murine melanoma models. Using syngeneic B16-F10 and B16-OVA tumor models, we demonstrate that intratumoral CAS injection significantly inhibits primary tumor growth and lung metastasis. Flow cytometry analysis reveals that CAS treatment increases splenic populations of CD3 + CD8 + cytotoxic T cells, CD3 + CD44 + memory T cells, and NK cells, while enhancing CD8 + T cell infiltration in tumor tissue.

ELISA results show elevated levels of pro-inflammatory cytokines (IFN-γ, TNF-α, and IL-2) in splenic culture supernatants and serum following CAS administration. Immunofluorescence staining confirms increased expression of CD8 and IFN-γ proteins in tumor tissues of CAS-treated mice.

Results indicate that CAS exerts its antitumor effects through direct cytotoxicity and by modulating both systemic and local immune responses. The dual action of CAS, which combines tumor necrosis with immunostimulation, positions it as a promising therapeutic agent for cancer treatment.

This study offers valuable insights into the mechanisms underlying CAS's action and underscores its potential clinical applications in oncology.

论文信息

作者
Shi Z、Xia Z、Huang S、Chen Z、Yin F、Xin H、Xu F
第一作者单位
Medical School of Chinese People's Liberation Army General Hospital, Beijing, China.China
通讯作者单位
Pharmaceutical Sciences Research Division, Department of Pharmacy, Medical Supplies Center, Chinese People's Liberation Army General Hospital, Beijing, China.China
期刊
Frontiers in immunology2025
原文标识
PubMed 40375992 · DOI 10.3389/fimmu.2025.1583275